PD Wealth Solutions

The year 2020 was like no other. For many, COVID-19 brought life almost to a standstill, and in doing so has changed the way people live, work and learn.

Following the historic Brexit vote in 2016, many firms in the UK were faced with a decision; to stay or leave?

After a relatively quiet year for mergers and acquisitions in 2017, PD Wealth Solutions' Paul Graham predicts this year will produce a bumper harvest of deals between 'Big Pharma' and Biotech.

Robert Marsh, Senior U.S. Equities specialist at PD Wealth Solutions discusses the evolution of the consumer staples industry in his recently published 2018 Investment Outlook.